Trials / Completed
CompletedNCT05214560
Prospective Clinical Evaluation of BD Spinal Needles
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (actual)
- Sponsor
- Becton, Dickinson and Company · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Post-market, observational study to assess the real-world safety and efficacy of BD Spinal Needles used in an on-market fashion.
Detailed description
Single-arm, post-market, observational, prospective study of participants who will receive neuraxial procedures with a BD Spinal Needle as part of their routine medical care. Patients will be followed from BD Spinal needle insertion up to 7 days after the insertion according to the routine medical care and site policy. Data collected will be gathered from the patient's medical charts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spinal needle | Insertion of a spinal needle to perform the neuraxial procedure. |
Timeline
- Start date
- 2022-02-14
- Primary completion
- 2022-07-22
- Completion
- 2022-07-22
- First posted
- 2022-01-28
- Last updated
- 2024-08-19
- Results posted
- 2024-08-19
Locations
6 sites across 5 countries: Austria, Finland, Germany, Spain, Switzerland
Source: ClinicalTrials.gov record NCT05214560. Inclusion in this directory is not an endorsement.